Vivos Inc.

RDGL ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-3.1M $-2.9M $-2.9M $-2.5M $-2.5M $-957.0K $-1.6M $-7.7M
Depreciation & Amortization — — — — — — — —
Depreciation $374 — — — — — — —
Amortization — — — — — — — —
Stock-Based Compensation — — — — $1.6M $2.2K $608.6K $1.2M
Net Cash from Operating Activities $-2.1M $-1.7M $-1.3M $-1.1M $-963.8K $-875.8K $-837.1K $-700.5K
Investing Activities
Capital Expenditures $103.2K — — — — — — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-103.2K — — — — — — —
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $1.5M $2.3M $1.2M $1.2M $1.7M $1.8M $852.0K $697.6K
Net Change in Cash $-654.0K $620.3K $-113.8K $99.9K $702.4K $883.3K $14.9K $-2.8K
Free Cash Flow $-2.2M — — — — — — —
← Newer Page 1 of 2 Older →